Vis enkel innførsel

dc.contributor.authorSerkland, Trond T.en_US
dc.contributor.authorSchjøtt, Janen_US
dc.contributor.authorBerg, Jon Andsnesen_US
dc.contributor.authorHerfindal, Larsen_US
dc.contributor.authorRiedel, Bettinaen_US
dc.contributor.authorSkrede, Siljeen_US
dc.date.accessioned2020-08-04T12:38:54Z
dc.date.available2020-08-04T12:38:54Z
dc.date.issued2019
dc.PublishedSerkland TT, Schjøtt JS, Berg JA, Herfindal L, Riedel B, Skrede S. Distribution of psychotropic drugs into lipoproteins. Therapeutic Drug Monitoring. 2019;41(6):766-771eng
dc.identifier.issn1536-3694
dc.identifier.issn0163-4356
dc.identifier.urihttps://hdl.handle.net/1956/23409
dc.description.abstractAim: The aim of this pilot study was to investigate whether psychotropic drugs frequently analyzed in a routine therapeutic drug monitoring laboratory bind to low-density lipoproteins/very-low-density lipoproteins (LDL/VLDL) in human serum. Methods: Drug concentrations in 20 serum sample pools containing one psychotropic drug each, and in the LDL/VLDL fractions extracted from the same samples, were measured by triple quadrupole liquid chromatography tandem mass spectrometry. The membrane permeability of the drugs was measured using a Parallel Artificial Membrane Permeability Assay. Results: Of the 20 antidepressants, antipsychotics, and antiepileptics examined, 7 drugs were detected in both the pooled serum samples and in the LDL/VLDL fraction. Binding of drugs to LDL/VLDL significantly correlated with high octanol: water partition coefficient (logP), high degree of protein binding, and a low polar surface area. The drugs found in LDL/VLDL, with the exception of aripiprazole, were also characterized by high or intermediate membrane permeability. Conclusions: The present results indicate that psychotropic drugs with certain characteristics bind to LDL/VLDL in blood. This further implies that lipoproteins could play an important role in drug transport.en_US
dc.language.isoengeng
dc.publisherWolters Kluwereng
dc.rightsAttribution-NonCommercial CC BY-NCeng
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/eng
dc.titleDistribution of psychotropic drugs into lipoproteinsen_US
dc.typePeer reviewed
dc.typeJournal article
dc.date.updated2019-12-19T08:28:01Z
dc.description.versionacceptedVersionen_US
dc.rights.holderCopyright 2019 Wolters Kluwer Health, Inc
dc.identifier.doihttps://doi.org/10.1097/ftd.0000000000000660
dc.identifier.cristin1701792
dc.source.journalTherapeutic Drug Monitoring
dc.source.pagenumber766-771
dc.identifier.citationTherapeutic Drug Monitoring. 2019;41(6):766-771
dc.source.volume41
dc.source.issue6


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Attribution-NonCommercial CC BY-NC
Med mindre annet er angitt, så er denne innførselen lisensiert som Attribution-NonCommercial CC BY-NC